| Acinetobacter baumannii |
Acinetobacter baumannii |
Inhibition |
22.54 |
% |
10.6019/CHEMBL4513141 |
| Candida albicans |
Candida albicans |
Inhibition |
1.9 |
% |
10.6019/CHEMBL4513141 |
| Canis lupus familiaris |
Brain |
Fu |
0.011 |
None |
10.1124/dmd.111.038778 |
| Canis lupus familiaris |
Canis familiaris |
Activity |
95.78 |
% |
10.1016/j.bmc.2008.10.040 |
| Canis lupus familiaris |
Canis familiaris |
Activity |
96.13 |
% |
10.1016/j.bmc.2008.10.040 |
| Canis lupus familiaris |
Canis familiaris |
Activity |
96.15 |
% |
10.1016/j.bmc.2008.10.040 |
| Canis lupus familiaris |
Plasma |
Fu |
0.018 |
None |
10.1124/dmd.110.037457 |
| Chlorocebus aethiops |
COS-7 |
Activity |
nan |
None |
10.1016/j.ejmech.2020.112258 |
| Cryptococcus neoformans |
Cryptococcus neoformans |
Inhibition |
-31.0 |
% |
10.6019/CHEMBL4513141 |
| Escherichia coli |
Escherichia coli |
Inhibition |
4.91 |
% |
10.6019/CHEMBL4513141 |
| Homo sapiens |
Acetylcholinesterase |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
17412.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
18287.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adhesion G-protein coupled receptor F1 |
%Inhib (Mean) |
-81.02 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Adhesion G-protein coupled receptor F1 |
%Inhib (Mean) |
-68.82 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Adhesion G-protein coupled receptor F1 |
%Inhib (Mean) |
-26.28 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Adhesion G-protein coupled receptor F1 |
%Inhib (Mean) |
13.64 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Adhesion G-protein coupled receptor F1 |
%Max (Mean) |
21.19 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Aldehyde dehydrogenase 1A1 |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
3000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
9554.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
3958.7 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
%Inhib (Mean) |
-32.7 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
%Inhib (Mean) |
-18.86 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
%Inhib (Mean) |
-10.54 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
%Inhib (Mean) |
12.4 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
%Max (Mean) |
5.0 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
12498.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Angiotensin-converting enzyme |
Inhibition |
97.0 |
% |
10.1021/jm400813y |
| Homo sapiens |
Angiotensin-converting enzyme |
Inhibition |
nan |
% |
10.1021/jm400813y |
| Homo sapiens |
Angiotensin-converting enzyme |
Ki |
6000.0 |
nM |
10.1021/jm400813y |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
IC50 |
0.33 |
nM |
10.1016/j.ejmech.2012.01.009 |
| Homo sapiens |
Apelin receptor |
%Inhib (Mean) |
-68.66 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Apelin receptor |
%Inhib (Mean) |
-55.67 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Apelin receptor |
%Inhib (Mean) |
-34.29 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Apelin receptor |
%Inhib (Mean) |
-22.83 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Apelin receptor |
%Max (Mean) |
1.073 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
ATP-binding cassette sub-family G member 2 |
IC50 |
16900.0 |
nM |
10.1016/j.ejmech.2022.114346 |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
%Inhib (Mean) |
-47.95 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Beta-2 adrenergic receptor |
%Inhib (Mean) |
-35.54 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Beta-2 adrenergic receptor |
%Inhib (Mean) |
-26.16 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Beta-2 adrenergic receptor |
%Inhib (Mean) |
-23.48 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Beta-2 adrenergic receptor |
%Max (Mean) |
-0.88 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Beta-3 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bile salt export pump |
AC50 |
5000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bile salt export pump |
IC50 |
16200.0 |
nM |
10.1002/hep.27206 |
| Homo sapiens |
Bile salt export pump |
IC50 |
16200.0 |
nM |
10.1093/toxsci/kfq269 |
| Homo sapiens |
Bile salt export pump |
IC50 |
16200.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Bradykinin B1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bromodomain-containing protein 4 |
Delta TM |
-1.136 |
C |
None |
| Homo sapiens |
C5a anaphylatoxin chemotactic receptor |
%Inhib (Mean) |
-46.38 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
C5a anaphylatoxin chemotactic receptor |
%Inhib (Mean) |
-40.21 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
C5a anaphylatoxin chemotactic receptor |
%Inhib (Mean) |
-36.11 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
C5a anaphylatoxin chemotactic receptor |
%Inhib (Mean) |
27.07 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
C5a anaphylatoxin chemotactic receptor |
%Max (Mean) |
-1.671 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Caco-2 |
logPapp |
-4.82 |
None |
10.1016/j.bmc.2009.08.022 |
| Homo sapiens |
Caco-2 |
logPapp |
-4.82 |
None |
10.1016/j.bmc.2011.03.011 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 2 |
IC50 |
60000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Casein kinase I delta |
Delta TM |
-0.004387 |
C |
None |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
2427.4 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin B receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Corticotropin releasing factor receptor 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Corticotropin releasing factor receptor 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
C-X3-C chemokine receptor 1 |
%Inhib (Mean) |
-44.47 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
C-X3-C chemokine receptor 1 |
%Inhib (Mean) |
-43.24 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
C-X3-C chemokine receptor 1 |
%Inhib (Mean) |
-41.78 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
C-X3-C chemokine receptor 1 |
%Inhib (Mean) |
-34.09 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
C-X3-C chemokine receptor 1 |
%Max (Mean) |
9.501 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Cyclin-dependent kinase 2 |
Delta TM |
-0.4205 |
C |
None |
| Homo sapiens |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cystic fibrosis transmembrane conductance regulator |
Activity |
nan |
None |
10.1016/j.ejmech.2021.113186 |
| Homo sapiens |
Cystic fibrosis transmembrane conductance regulator |
Kd |
189300.0 |
nM |
10.1016/j.ejmech.2021.113186 |
| Homo sapiens |
Cytochrome P450 1A2 |
IC50 |
50000.0 |
nM |
10.1124/dmd.112.048264 |
| Homo sapiens |
Cytochrome P450 2C19 |
IC50 |
50000.0 |
nM |
10.1124/dmd.112.048264 |
| Homo sapiens |
Cytochrome P450 2C9 |
Activity |
nan |
None |
10.1124/dmd.110.037259 |
| Homo sapiens |
Cytochrome P450 2C9 |
IC50 |
4780.0 |
nM |
10.1124/dmd.112.048264 |
| Homo sapiens |
Cytochrome P450 2D6 |
IC50 |
50000.0 |
nM |
10.1124/dmd.112.048264 |
| Homo sapiens |
Cytochrome P450 2J2 |
IC50 |
420.0 |
nM |
10.1124/dmd.112.048264 |
| Homo sapiens |
Cytochrome P450 2J2 |
IC50 |
540.0 |
nM |
10.1124/dmd.112.048264 |
| Homo sapiens |
Cytochrome P450 2J2 |
Ki |
100.0 |
nM |
10.1124/dmd.112.048264 |
| Homo sapiens |
Cytochrome P450 2J2 |
Ki |
190.0 |
nM |
10.1124/dmd.112.048264 |
| Homo sapiens |
Cytochrome P450 2J2 |
Ratio IC50 |
1.0 |
None |
10.1124/dmd.112.048264 |
| Homo sapiens |
Cytochrome P450 3A4 |
IC50 |
50000.0 |
nM |
10.1124/dmd.112.048264 |
| Homo sapiens |
Cytochrome P450 3A4 |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
Delta opioid receptor |
AC50 |
15906.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D4 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Endoplasmic reticulum-associated amyloid beta-peptide-binding protein |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Endothelin receptor ET-A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Endothelin receptor ET-B |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor beta |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Eyes absent homolog 2 |
Potency |
28183.8 |
nM |
None |
| Homo sapiens |
Fibroblast |
Growth Rate |
0.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Growth Rate |
1.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast growth factor receptor 3 |
Delta TM |
0.3194 |
C |
None |
| Homo sapiens |
GABA-B receptor 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Gastric inhibitory polypeptide receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Ghrelin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucagon-like peptide 1 receptor |
%Inhib (Mean) |
-47.0 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Glucagon-like peptide 1 receptor |
%Inhib (Mean) |
-29.49 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Glucagon-like peptide 1 receptor |
%Inhib (Mean) |
-26.42 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Glucagon-like peptide 1 receptor |
%Inhib (Mean) |
-13.86 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Glucagon-like peptide 1 receptor |
%Max (Mean) |
0.69 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Glucagon receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucose-dependent insulinotropic receptor |
%Inhib (Mean) |
-77.17 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Glucose-dependent insulinotropic receptor |
%Inhib (Mean) |
-58.02 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Glucose-dependent insulinotropic receptor |
%Inhib (Mean) |
-25.22 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Glucose-dependent insulinotropic receptor |
%Inhib (Mean) |
5.107 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Glucose-dependent insulinotropic receptor |
%Max (Mean) |
-3.14 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Glycine receptor subunit alpha-1 |
Activity |
120.0 |
% |
10.1021/jm501873p |
| Homo sapiens |
Glycine receptor subunit alpha-1 |
EC50 |
3200.0 |
nM |
10.1021/jm501873p |
| Homo sapiens |
Glycine receptor subunit alpha-1 |
%max |
210.0 |
% |
10.1021/jm501873p |
| Homo sapiens |
Glycogen synthase kinase-3 beta |
Delta TM |
-0.5726 |
C |
None |
| Homo sapiens |
G-protein coupled receptor 120 |
%Inhib (Mean) |
-196.96 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
G-protein coupled receptor 120 |
%Inhib (Mean) |
-56.0 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
G-protein coupled receptor 120 |
%Inhib (Mean) |
-45.97 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
G-protein coupled receptor 120 |
%Inhib (Mean) |
-15.42 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
G-protein coupled receptor 120 |
%Max (Mean) |
-1.6 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
G-protein coupled receptor 35 |
%Inhib (Mean) |
-10.77 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
G-protein coupled receptor 35 |
%Max (Mean) |
25.04 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Guanine nucleotide-binding protein G(s), subunit alpha |
Potency |
3162.3 |
nM |
None |
| Homo sapiens |
HEK-293T |
Growth Rate |
0.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HepG2 |
IC50 |
10000.0 |
nM |
10.1073/pnas.1118370109 |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-0.61 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
65.05 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
4466.8 |
nM |
None |
| Homo sapiens |
Homo sapiens |
Activity |
0.9 |
% |
10.1016/j.ejmech.2009.11.034 |
| Homo sapiens |
Homo sapiens |
Activity |
nan |
None |
10.1002/hep.27206 |
| Homo sapiens |
Homo sapiens |
AUC |
1835.17 |
ng.hr.mL-1 |
10.1093/toxsci/kft176 |
| Homo sapiens |
Homo sapiens |
AUC |
2469.9 |
ng.hr.mL-1 |
10.1124/dmd.112.046292 |
| Homo sapiens |
Homo sapiens |
AUC |
3010.9 |
ng.hr.mL-1 |
10.1124/dmd.112.046292 |
| Homo sapiens |
Homo sapiens |
AUC |
3133.4 |
ng.hr.mL-1 |
10.1124/dmd.112.046292 |
| Homo sapiens |
Homo sapiens |
AUC |
3231.4 |
ng.hr.mL-1 |
10.1124/dmd.112.046292 |
| Homo sapiens |
Homo sapiens |
AUC |
3399.7 |
ng.hr.mL-1 |
10.1124/dmd.112.046292 |
| Homo sapiens |
Homo sapiens |
AUC |
3677.2 |
ng.hr.mL-1 |
10.1124/dmd.112.046292 |
| Homo sapiens |
Homo sapiens |
AUC |
3682.7 |
ng.hr.mL-1 |
10.1124/dmd.112.046292 |
| Homo sapiens |
Homo sapiens |
CL |
0.0 |
mL.min-1.kg-1 |
10.1124/dmd.111.043984 |
| Homo sapiens |
Homo sapiens |
CL |
0.0 |
mL.min-1.kg-1 |
10.1124/dmd.112.045476 |
| Homo sapiens |
Homo sapiens |
CL |
8.3 |
mL.min-1.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
CL |
8.4 |
mL.min-1.kg-1 |
10.1021/jm900403j |
| Homo sapiens |
Homo sapiens |
CL |
8.4 |
mL.min-1.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
CL |
8.4 |
mL.min-1.kg-1 |
10.1124/dmd.110.037457 |
| Homo sapiens |
Homo sapiens |
CL |
8.4 |
mL.min-1.kg-1 |
10.1124/dmd.112.045476 |
| Homo sapiens |
Homo sapiens |
CL |
12.32 |
mL.min-1.kg-1 |
10.1124/dmd.111.043984 |
| Homo sapiens |
Homo sapiens |
CL |
17.8 |
mL.min-1.kg-1 |
10.1124/dmd.110.037457 |
| Homo sapiens |
Homo sapiens |
CL |
163.33 |
mL.min-1.kg-1 |
10.1124/dmd.112.046292 |
| Homo sapiens |
Homo sapiens |
CL |
195.0 |
mL.min-1.kg-1 |
10.1124/dmd.112.046292 |
| Homo sapiens |
Homo sapiens |
CL |
231.67 |
mL.min-1.kg-1 |
10.1124/dmd.112.046292 |
| Homo sapiens |
Homo sapiens |
CL |
243.33 |
mL.min-1.kg-1 |
10.1124/dmd.112.046292 |
| Homo sapiens |
Homo sapiens |
CL |
245.0 |
mL.min-1.kg-1 |
10.1124/dmd.112.046292 |
| Homo sapiens |
Homo sapiens |
CL |
283.33 |
mL.min-1.kg-1 |
10.1124/dmd.112.046292 |
| Homo sapiens |
Homo sapiens |
CL |
298.33 |
mL.min-1.kg-1 |
10.1124/dmd.112.046292 |
| Homo sapiens |
Homo sapiens |
CL_renal |
0.08 |
mL.min-1.kg-1 |
10.1021/jm900403j |
| Homo sapiens |
Homo sapiens |
CL_renal |
0.1 |
mL.min-1.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Cmax |
548.16 |
nM |
10.1124/dmd.112.046292 |
| Homo sapiens |
Homo sapiens |
Cmax |
849.93 |
nM |
10.1124/dmd.112.046292 |
| Homo sapiens |
Homo sapiens |
Cmax |
851.0 |
nM |
10.1002/hep.27206 |
| Homo sapiens |
Homo sapiens |
Cmax |
866.06 |
nM |
10.1124/dmd.112.046292 |
| Homo sapiens |
Homo sapiens |
Cmax |
959.52 |
nM |
10.1124/dmd.112.046292 |
| Homo sapiens |
Homo sapiens |
Cmax |
967.49 |
nM |
10.1124/dmd.112.046292 |
| Homo sapiens |
Homo sapiens |
Cmax |
991.97 |
nM |
10.1124/dmd.112.046292 |
| Homo sapiens |
Homo sapiens |
Cmax |
1147.43 |
nM |
10.1124/dmd.112.046292 |
| Homo sapiens |
Homo sapiens |
Css |
0.149 |
uM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Homo sapiens |
DILI_Concern |
nan |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
DILI_severity_class |
3.0 |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
Fa |
0.43 |
None |
10.1124/dmd.112.045476 |
| Homo sapiens |
Homo sapiens |
Fa |
0.9 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
F_fraction |
0.43 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Fg |
0.75 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Fh |
0.64 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
T1/2 |
7.29 |
hr |
10.1124/dmd.110.037457 |
| Homo sapiens |
Homo sapiens |
T1/2 |
25.1 |
hr |
10.1124/dmd.112.046292 |
| Homo sapiens |
Homo sapiens |
T1/2 |
28.7 |
hr |
10.1124/dmd.112.046292 |
| Homo sapiens |
Homo sapiens |
T1/2 |
29.1 |
hr |
10.1124/dmd.112.046292 |
| Homo sapiens |
Homo sapiens |
T1/2 |
29.7 |
hr |
10.1124/dmd.112.046292 |
| Homo sapiens |
Homo sapiens |
T1/2 |
30.1 |
hr |
10.1124/dmd.112.046292 |
| Homo sapiens |
Homo sapiens |
T1/2 |
33.1 |
hr |
10.1124/dmd.112.046292 |
| Homo sapiens |
Homo sapiens |
T1/2 |
33.9 |
hr |
10.1124/dmd.112.046292 |
| Homo sapiens |
Homo sapiens |
Tmax |
1.0 |
hr |
10.1124/dmd.112.046292 |
| Homo sapiens |
Homo sapiens |
Tmax |
1.1 |
hr |
10.1124/dmd.112.046292 |
| Homo sapiens |
Homo sapiens |
Tmax |
1.3 |
hr |
10.1124/dmd.112.046292 |
| Homo sapiens |
Homo sapiens |
Tmax |
1.4 |
hr |
10.1124/dmd.112.046292 |
| Homo sapiens |
Homo sapiens |
Vdss |
5.3 |
L.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Vdss |
5.3 |
L.kg-1 |
10.1124/dmd.110.037457 |
| Homo sapiens |
Isocitrate dehydrogenase [NADP] cytoplasmic |
Potency |
8199.5 |
nM |
None |
| Homo sapiens |
K562 |
Activity |
21.0 |
% |
10.1016/j.ejmech.2021.113285 |
| Homo sapiens |
K562 |
Activity |
57.0 |
% |
10.1016/j.ejmech.2021.113285 |
| Homo sapiens |
K562 |
Activity |
63.0 |
% |
10.1016/j.ejmech.2021.113285 |
| Homo sapiens |
K562-IMA[r] |
Activity |
nan |
None |
10.1016/j.ejmech.2019.111748 |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Lipoxin A4 receptor |
%Inhib (Mean) |
-22.13 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Lipoxin A4 receptor |
%Inhib (Mean) |
-16.27 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Lipoxin A4 receptor |
%Inhib (Mean) |
-15.38 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Lipoxin A4 receptor |
%Inhib (Mean) |
1.86 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Lipoxin A4 receptor |
%Max (Mean) |
-1.86 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Liver microsome |
CL |
9.93 |
mL.min-1.kg-1 |
10.1124/dmd.111.043984 |
| Homo sapiens |
Liver microsome |
CL |
76.9 |
mL.min-1.g-1 |
10.1124/dmd.111.043984 |
| Homo sapiens |
Liver microsome |
CL |
395.0 |
mL.min-1.g-1 |
10.1124/dmd.111.043984 |
| Homo sapiens |
Liver microsome |
Drug metabolism |
1.0 |
ml/min.kg |
10.1124/dmd.111.043984 |
| Homo sapiens |
Liver microsome |
Fu |
0.07 |
None |
10.1124/dmd.111.043984 |
| Homo sapiens |
Liver microsome |
Fu |
0.65 |
None |
10.1124/dmd.111.043984 |
| Homo sapiens |
Liver microsome |
Ratio |
1.6 |
None |
10.1124/dmd.111.043984 |
| Homo sapiens |
Liver microsome |
Stability |
97.7 |
% |
10.1124/dmd.112.048264 |
| Homo sapiens |
Lysine-specific demethylase 4D-like |
Potency |
11220.2 |
nM |
None |
| Homo sapiens |
Lysine-specific demethylase 4D-like |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
MAP kinase ERK2 |
Delta TM |
-0.1754 |
C |
None |
| Homo sapiens |
MAP kinase ERK2 |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 4 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Motilin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Multidrug and toxin extrusion protein 1 |
IC50 |
17900.0 |
nM |
10.1021/jm301302s |
| Homo sapiens |
Multidrug and toxin extrusion protein 1 |
Inhibition |
38.0 |
% |
10.1021/jm301302s |
| Homo sapiens |
Multidrug resistance-associated protein 4 |
IC50 |
36000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
2564.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
3700.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
10779.7 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
17631.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
5157.5 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neurokinin 1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide S receptor |
Potency |
1258.9 |
nM |
None |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neurotensin receptor 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
23109.3 |
nM |
None |
| Homo sapiens |
Parathyroid hormone receptor |
Potency |
35481.3 |
nM |
None |
| Homo sapiens |
Peregrin |
Delta TM |
-0.8942 |
C |
None |
| Homo sapiens |
Peroxisome proliferator-activated receptor alpha |
EC50 |
10000.0 |
nM |
10.1016/j.bmcl.2009.12.107 |
| Homo sapiens |
Peroxisome proliferator-activated receptor alpha |
IC50 |
10000.0 |
nM |
10.1016/j.bmcl.2009.12.107 |
| Homo sapiens |
Peroxisome proliferator-activated receptor delta |
EC50 |
10000.0 |
nM |
10.1016/j.bmcl.2009.12.107 |
| Homo sapiens |
Peroxisome proliferator-activated receptor delta |
IC50 |
10000.0 |
nM |
10.1016/j.bmcl.2009.12.107 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
AC50 |
18999.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
Activity |
21.9 |
% |
10.1021/jm901272d |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
Activity |
44.8 |
% |
10.1016/j.ejmech.2016.07.072 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
Activity |
47.0 |
% |
10.1016/j.bmc.2010.06.102 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
Activity |
48.2 |
% |
10.1016/j.ejmech.2016.07.072 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
Activity |
49.0 |
% |
10.1016/j.bmcl.2009.12.107 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
Activity |
nan |
None |
10.1016/j.ejmech.2016.11.051 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
Activity |
nan |
None |
10.1016/j.ejmech.2018.08.082 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
Alpha max |
60.5 |
% |
10.1016/j.ejmech.2020.112258 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
EC50 |
700.0 |
nM |
10.1016/j.ejmech.2016.07.072 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
EC50 |
1520.0 |
nM |
10.1016/j.bmcl.2012.11.088 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
EC50 |
1520.0 |
nM |
10.1021/jm200409s |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
EC50 |
2020.0 |
nM |
10.1016/j.bmcl.2009.12.107 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
EC50 |
2020.0 |
nM |
10.1016/j.bmcl.2014.01.004 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
EC50 |
2020.0 |
nM |
10.1016/j.ejmech.2019.04.030 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
EC50 |
3400.0 |
nM |
10.1016/j.bmc.2010.06.102 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
EC50 |
4280.0 |
nM |
10.1016/j.ejmech.2019.111748 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
EC50 |
4300.0 |
nM |
10.1016/j.ejmech.2020.112258 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
EC50 |
4500.0 |
nM |
10.1021/jm501155f |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
EC50 |
4700.0 |
nM |
10.1016/j.ejmech.2016.07.072 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
EC50 |
4710.0 |
nM |
10.1016/j.ejmech.2016.08.027 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
EC50 |
4970.0 |
nM |
10.1016/j.ejmech.2016.11.051 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
Emax |
33.0 |
% |
10.1021/jm200409s |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
IC50 |
12200.0 |
nM |
10.1016/j.bmcl.2009.12.107 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
Inhibition |
61.3 |
% |
10.1016/j.ejmech.2016.07.072 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
Inhibition |
91.0 |
% |
10.1016/j.ejmech.2016.07.072 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
Intrinsic activity |
59.1 |
% |
10.1016/j.ejmech.2019.111748 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
Intrinsic activity |
78.0 |
% |
10.1016/j.ejmech.2019.111748 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
Ki |
1080.0 |
nM |
10.1021/acsmedchemlett.2c00511 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
%max |
21.2 |
% |
10.1007/s00044-008-9153-9 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
%max |
30.0 |
% |
10.1021/jm501155f |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
%max |
33.0 |
% |
10.1016/j.bmcl.2012.11.088 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
%max |
50.9 |
% |
10.1016/j.ejmech.2016.08.027 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
max activation |
39.3 |
% |
10.1016/j.ejmech.2016.11.051 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
max activation |
49.0 |
% |
10.1016/j.bmcl.2014.01.004 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
max activation |
59.8 |
% |
10.1016/j.ejmech.2021.113285 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
29906.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4A |
AC50 |
13523.2 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
7099.3 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Plasma |
Fu |
0.003 |
None |
10.1124/dmd.110.037457 |
| Homo sapiens |
Pregnane X receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Prelamin-A/C |
Potency |
0.8 |
nM |
None |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Runt-related transcription factor 1/Core-binding factor subunit beta |
Potency |
6309.6 |
nM |
None |
| Homo sapiens |
Serine/threonine-protein kinase Aurora-A |
Delta TM |
0.03632 |
C |
None |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
15874.5 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
6328.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 7 (5-HT7) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Signal transducer and activator of transcription 5A |
Inhibition |
nan |
% |
10.1016/j.ejmech.2020.112258 |
| Homo sapiens |
Sodium channel protein type V alpha subunit |
AC50 |
27299.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Solute carrier family 22 member 3 |
Inhibition |
81.6 |
% |
10.1021/acs.jmedchem.2c01075 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
IC50 |
1862.09 |
nM |
10.1124/mol.112.084152 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Inhibition |
77.57 |
% |
10.1124/mol.112.084152 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Inhibition |
109.4 |
% |
10.1021/jm300212s |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Ki |
1030.0 |
nM |
10.1124/mol.112.084152 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Activity |
nan |
None |
10.1038/nrd3028 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
IC50 |
1258.93 |
nM |
10.1124/mol.112.084152 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Inhibition |
41.88 |
% |
10.1124/mol.112.084152 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Inhibition |
91.5 |
% |
10.1021/jm300212s |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Ki |
960.0 |
nM |
10.1124/mol.112.084152 |
| Homo sapiens |
Solute carrier organic anion transporter family member 2B1 |
Inhibition |
94.9 |
% |
10.1021/jm300212s |
| Homo sapiens |
Sphingosine 1-phosphate receptor Edg-1 |
%Inhib (Mean) |
-24.95 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Sphingosine 1-phosphate receptor Edg-1 |
%Inhib (Mean) |
-13.32 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Sphingosine 1-phosphate receptor Edg-1 |
%Inhib (Mean) |
-3.17 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Sphingosine 1-phosphate receptor Edg-1 |
%Inhib (Mean) |
17.7 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Sphingosine 1-phosphate receptor Edg-1 |
%Max (Mean) |
-3.771 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
TAR DNA-binding protein 43 |
Potency |
316.2 |
nM |
None |
| Homo sapiens |
Thrombin |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
1000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
14478.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
18110.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane A2 receptor |
MEC |
5.0 |
uM |
10.1021/acs.jmedchem.0c00262 |
| Homo sapiens |
Transcription intermediary factor 1-alpha |
Delta TM |
-0.249 |
C |
None |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
1.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Type-1 angiotensin II receptor |
Affinity |
1.0 |
nM |
10.1021/jm049024x |
| Homo sapiens |
Type-1 angiotensin II receptor |
AT1 affinity |
1.0 |
nM l-1 |
10.1021/jm0204237 |
| Homo sapiens |
Type-1 angiotensin II receptor |
Emax |
1.0 |
hr |
10.1021/jm049024x |
| Homo sapiens |
Type-1 angiotensin II receptor |
IC50 |
0.49 |
nM |
10.1016/j.bmcl.2012.11.088 |
| Homo sapiens |
Type-1 angiotensin II receptor |
IC50 |
0.49 |
nM |
10.1021/jm200409s |
| Homo sapiens |
Type-1 angiotensin II receptor |
IC50 |
1.0 |
nM |
10.1016/j.bmc.2012.05.056 |
| Homo sapiens |
Type-1 angiotensin II receptor |
IC50 |
1.0 |
nM |
10.1016/j.ejmech.2012.01.009 |
| Homo sapiens |
Type-1 angiotensin II receptor |
IC50 |
1.0 |
nM |
10.1016/j.ejmech.2013.08.014 |
| Homo sapiens |
Type-1 angiotensin II receptor |
IC50 |
2.0 |
nM |
10.1016/j.bmcl.2014.01.004 |
| Homo sapiens |
Type-1 angiotensin II receptor |
IC50 |
2.0 |
nM |
10.1016/j.ejmech.2019.04.030 |
| Homo sapiens |
Type-1 angiotensin II receptor |
IC50 |
3.0 |
nM |
10.1016/j.bmcl.2009.12.107 |
| Homo sapiens |
Type-1 angiotensin II receptor |
IC50 |
150.0 |
nM |
10.1016/j.bmc.2012.05.056 |
| Homo sapiens |
Type-1 angiotensin II receptor |
%Inhib (Mean) |
94.01 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Type-1 angiotensin II receptor |
%Inhib (Mean) |
95.84 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Type-1 angiotensin II receptor |
%Inhib (Mean) |
100.37 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Type-1 angiotensin II receptor |
%Inhib (Mean) |
103.06 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Type-1 angiotensin II receptor |
%Max (Mean) |
-3.573 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Type-1 angiotensin II receptor |
pKa |
4.5 |
None |
10.1021/jm049024x |
| Homo sapiens |
Type-1 angiotensin II receptor |
Relative binding affinity |
10.0 |
None |
10.1021/jm0204237 |
| Homo sapiens |
Tyrosine-protein kinase ABL |
Delta TM |
-0.002726 |
C |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
18356.4 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
23109.3 |
nM |
None |
| Homo sapiens |
U2OS |
Growth Rate |
0.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Growth Rate |
1.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1 |
Potency |
50118.7 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 2 |
Potency |
10000.0 |
nM |
None |
| Homo sapiens |
UDP-glucuronosyltransferase 1-3 |
CL |
0.124 |
mL.min-1.g-1 |
10.1124/dmd.111.043984 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-3 |
CL |
0.438 |
mL.min-1.g-1 |
10.1124/dmd.111.043984 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-3 |
CL |
0.439 |
mL.min-1.g-1 |
10.1124/dmd.111.043984 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-3 |
CL |
1.88 |
mL.min-1.g-1 |
10.1124/dmd.111.043984 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-3 |
CL |
3.08 |
mL.min-1.g-1 |
10.1124/dmd.111.043984 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-3 |
CL |
15.8 |
mL.min-1.g-1 |
10.1124/dmd.111.043984 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-3 |
Ratio |
0.028 |
None |
10.1124/dmd.111.043984 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-3 |
Ratio |
0.04 |
None |
10.1124/dmd.111.043984 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-3 |
Ratio |
0.119 |
None |
10.1124/dmd.111.043984 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-3 |
Ratio |
0.142 |
None |
10.1124/dmd.111.043984 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-3 |
Ratio |
0.233 |
None |
10.1124/dmd.111.043984 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-3 |
Ratio |
0.284 |
None |
10.1124/dmd.111.043984 |
| Homo sapiens |
Vascular endothelial growth factor receptor 2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vitamin D receptor |
Potency |
28183.8 |
nM |
None |
| Klebsiella pneumoniae |
Klebsiella pneumoniae |
Inhibition |
15.0 |
% |
10.6019/CHEMBL4513141 |
| Macaca fascicularis |
Brain |
Fu |
0.013 |
None |
10.1124/dmd.111.038778 |
| Macaca mulatta |
Plasma |
Fu |
0.008 |
None |
10.1124/dmd.110.037457 |
| Mus musculus |
3T3-L1 |
Activity |
nan |
None |
10.1007/s00044-008-9152-x |
| Mus musculus |
3T3-L1 |
Activity |
nan |
None |
10.1007/s00044-008-9153-9 |
| Mus musculus |
Brain |
Fu |
0.01 |
None |
10.1124/dmd.111.038778 |
| Mus musculus |
Indoleamine 2,3-dioxygenase 2 |
Inhibition |
55.0 |
% |
10.1016/j.bmcl.2012.10.010 |
| Mus musculus |
Mus musculus |
Activity |
0.6 |
% |
10.1021/acs.jmedchem.0c00542 |
| Mus musculus |
Mus musculus |
Activity |
0.6 |
None |
10.1021/acs.jmedchem.9b01440 |
| Mus musculus |
Mus musculus |
Activity |
2.9 |
None |
10.1021/acs.jmedchem.9b01440 |
| Mus musculus |
Mus musculus |
Activity |
23.0 |
% |
10.1021/acs.jmedchem.9b01440 |
| Mus musculus |
Mus musculus |
Activity |
nan |
None |
10.1021/acs.jmedchem.0c00542 |
| Mus musculus |
Mus musculus |
Activity |
nan |
None |
10.1021/acs.jmedchem.9b01440 |
| Mus musculus |
Peroxisome proliferator-activated receptor alpha |
EC50 |
10000.0 |
nM |
10.1016/j.bmcl.2009.12.107 |
| Mus musculus |
Peroxisome proliferator-activated receptor delta |
EC50 |
10000.0 |
nM |
10.1016/j.bmcl.2009.12.107 |
| Mus musculus |
Peroxisome proliferator-activated receptor gamma |
Activity |
45.0 |
% |
10.1016/j.bmcl.2009.12.107 |
| Mus musculus |
Peroxisome proliferator-activated receptor gamma |
Activity |
nan |
None |
10.1016/j.bmcl.2018.12.043 |
| Mus musculus |
Peroxisome proliferator-activated receptor gamma |
Activity |
nan |
None |
10.1016/j.ejmech.2016.08.027 |
| Mus musculus |
Peroxisome proliferator-activated receptor gamma |
EC50 |
4060.0 |
nM |
10.1016/j.bmcl.2009.12.107 |
| Mus musculus |
Peroxisome proliferator-activated receptor gamma |
FC |
2.0 |
None |
10.1016/j.ejmech.2016.08.027 |
| Mus musculus |
Peroxisome proliferator-activated receptor gamma |
%max |
21.2 |
% |
10.1007/s00044-008-9152-x |
| Mus musculus |
Plasma |
Fu |
0.071 |
None |
10.1124/dmd.110.037457 |
| Photinus pyralis |
Luciferin 4-monooxygenase |
Potency |
9074.3 |
nM |
None |
| Photinus pyralis |
Luciferin 4-monooxygenase |
Potency |
13459.1 |
nM |
None |
| Photobacterium phosphoreum |
Photobacterium phosphoreum |
LC50 |
100.0 |
ug.mL-1 |
10.1016/j.bmc.2012.05.056 |
| Photobacterium phosphoreum |
Photobacterium phosphoreum |
LC50 |
100.0 |
ug.mL-1 |
10.1016/j.ejmech.2012.01.009 |
| Plasmodium |
Plasmodium |
IC50 |
25.0 |
nM |
10.1016/j.ejmech.2020.112275 |
| Plasmodium berghei |
Plasmodium berghei |
IC50 |
25.0 |
nM |
10.1073/pnas.1118370109 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
1612.0 |
nM |
10.1128/aac.00431-10 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
5000.0 |
nM |
10.1073/pnas.1118370109 |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
1510.1 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
3793.3 |
nM |
None |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
Inhibition |
38.9 |
% |
10.6019/CHEMBL4513141 |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Brain |
Fu |
0.013 |
None |
10.1124/dmd.111.038778 |
| Rattus norvegicus |
Brain |
Fu |
0.017 |
None |
10.1124/dmd.111.038778 |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Liver |
IC50 |
70.5 |
nM |
10.1002/hep.27206 |
| Rattus norvegicus |
Peripheral myelin protein 22 |
Potency |
28695.4 |
nM |
None |
| Rattus norvegicus |
Plasma |
Fu |
0.004 |
None |
10.1021/jm901371v |
| Rattus norvegicus |
Plasma |
Fu |
0.007 |
None |
10.1124/dmd.110.037457 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
13.2 |
ug ml-1 |
10.1021/jm200409s |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
157.0 |
g |
10.1021/jm200409s |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
510.0 |
mg/dl |
10.1021/jm200409s |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
935.0 |
mg/dl |
10.1021/jm200409s |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
nan |
None |
10.1016/j.ejmech.2016.03.021 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
nan |
None |
10.1021/jm200409s |
| Rattus norvegicus |
Rattus norvegicus |
MABP |
42.0 |
mmHg |
10.1021/jm00077a007 |
| Rattus norvegicus |
Rattus norvegicus |
MABP |
68.0 |
mmHg |
10.1021/jm00077a007 |
| Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
79432.8 |
nM |
None |
| Rattus norvegicus |
Type-1A angiotensin II receptor |
Ki |
0.23 |
nM |
10.1007/s00044-008-9153-9 |
| Rattus norvegicus |
Type-1A angiotensin II receptor |
Ki |
0.23 |
nM |
10.1021/jm901272d |
| Rattus norvegicus |
Type-1A angiotensin II receptor |
Ki |
nan |
None |
10.1007/s00044-008-9152-x |
| Rattus norvegicus |
Type-1B angiotensin II receptor |
IC50 |
3.0 |
nM |
10.1021/jm00077a007 |
| Rattus norvegicus |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Voltage-gated N-type calcium channel alpha-1B subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
15.51 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.1182 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.0 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
1.27 |
% |
10.21203/rs.3.rs-23951/v1 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition index |
0.7519 |
None |
10.1101/2020.04.03.023846 |
| Staphylococcus aureus |
Staphylococcus aureus |
Inhibition |
33.03 |
% |
10.6019/CHEMBL4513141 |
| None |
ADMET |
Activity |
9.0 |
% |
10.1021/acs.jmedchem.0c00542 |
| None |
ADMET |
Activity |
nan |
None |
10.1021/acs.jmedchem.0c00542 |
| None |
ADMET |
Biotransformation |
nan |
None |
10.1038/s41586-019-1291-3 |
| None |
ADMET |
CL |
3.0 |
mL.min-1.g-1 |
10.6019/CHEMBL3301361 |
| None |
ADMET |
CL |
3.98 |
uL.min-1.(10^6cells)-1 |
10.6019/CHEMBL3301361 |
| None |
ADMET |
CL |
4.3 |
mL.min-1.kg-1 |
10.1021/acs.jmedchem.0c01033 |
| None |
ADMET |
CL |
8.4 |
mL.min-1.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
CL |
9.2 |
mL.min-1.kg-1 |
10.1021/acs.jmedchem.0c01033 |
| None |
ADMET |
CL |
9.72 |
mL.min-1.g-1 |
10.1124/dmd.111.043984 |
| None |
ADMET |
CL |
10.2 |
mL.min-1.kg-1 |
10.1021/acs.jmedchem.0c01033 |
| None |
ADMET |
CL |
20.0 |
mL.min-1.g-1 |
10.1124/dmd.112.045476 |
| None |
ADMET |
CL |
21.3 |
mL.min-1.g-1 |
10.1124/dmd.111.043984 |
| None |
ADMET |
CL |
21.7 |
mL.min-1.g-1 |
10.1124/dmd.112.045476 |
| None |
ADMET |
CL |
34.3 |
mL.min-1.g-1 |
10.1124/dmd.111.043984 |
| None |
ADMET |
CL |
39.0 |
mL.min-1.kg-1 |
10.1021/acs.jmedchem.0c01033 |
| None |
ADMET |
CL |
91.4 |
mL.min-1.g-1 |
10.1124/dmd.111.043984 |
| None |
ADMET |
CL |
nan |
None |
10.1124/dmd.112.045476 |
| None |
ADMET |
CL free |
nan |
None |
10.1124/dmd.112.045476 |
| None |
ADMET |
CL_renal |
5.0 |
ml s-1 |
10.1021/jm0204237 |
| None |
ADMET |
CLtotal |
19.0 |
ml s-1 |
10.1021/jm0204237 |
| None |
ADMET |
F |
43.0 |
% |
10.1021/jm0204237 |
| None |
ADMET |
F |
58.0 |
% |
10.1021/jm049024x |
| None |
ADMET |
Fm |
0.118 |
None |
10.1124/dmd.110.037457 |
| None |
ADMET |
Fm |
0.396 |
None |
10.1124/dmd.110.037457 |
| None |
ADMET |
Fm |
0.47 |
None |
10.1124/dmd.110.037457 |
| None |
ADMET |
Fm |
0.99 |
None |
10.1124/dmd.110.037457 |
| None |
ADMET |
Fu |
6e-05 |
None |
10.1021/acs.jmedchem.0c01033 |
| None |
ADMET |
Fu |
0.000125 |
None |
10.1021/acs.jmedchem.0c01033 |
| None |
ADMET |
Fu |
0.008 |
None |
10.1124/dmd.111.038778 |
| None |
ADMET |
Fu |
0.48 |
None |
10.1124/dmd.111.043984 |
| None |
ADMET |
Modification of adsorbed drug |
16.0 |
% |
10.1021/jm049024x |
| None |
ADMET |
MRT |
11.0 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
Papp |
12.0 |
10^-6 cm/s |
10.1021/acs.jmedchem.0c01033 |
| None |
ADMET |
pKa |
4.5 |
None |
10.1021/jm0204237 |
| None |
ADMET |
PPB |
98.25 |
% |
10.6019/CHEMBL3301361 |
| None |
ADMET |
PPB |
99.23 |
% |
10.6019/CHEMBL3301361 |
| None |
ADMET |
PPB |
99.62 |
% |
10.6019/CHEMBL3301361 |
| None |
ADMET |
Ratio |
0.61 |
None |
10.1021/acs.jmedchem.0c01033 |
| None |
ADMET |
Ratio |
0.65 |
None |
10.1021/acs.jmedchem.0c01033 |
| None |
ADMET |
Ratio |
1.6 |
None |
10.1124/dmd.111.043984 |
| None |
ADMET |
Ratio IC50 |
10.0 |
None |
10.1124/dmd.112.048264 |
| None |
ADMET |
T1/2 |
20.0 |
hr |
10.1021/jm0204237 |
| None |
ADMET |
T1/2 |
20.0 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
T1/2 |
24.0 |
hr |
10.1021/jm049024x |
| None |
ADMET |
Vd |
4.54 |
L.kg-1 |
10.1021/jm049024x |
| None |
ADMET |
Vdss |
5.3 |
L.kg-1 |
10.1124/dmd.108.020479 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx1000865 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx900326k |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1124/dmd.110.035113 |
| None |
Hepatotoxicity |
HepSE_bilirubinemia |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholecystitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholelithiasis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cirrhosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_Combined Scores |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_elevated liver function tests |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic failure |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic necrosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatomegaly |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_jaundice |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver disease |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver fatty |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver function tests abnormal |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Molecular identity unknown |
Fu |
0.005 |
None |
10.1124/dmd.111.043984 |
| None |
NON-PROTEIN TARGET |
Fu |
0.004 |
None |
10.1124/dmd.108.020479 |
| None |
NON-PROTEIN TARGET |
Fu |
0.014 |
None |
10.1124/dmd.111.038778 |
| None |
NON-PROTEIN TARGET |
Fu |
0.42 |
None |
10.1021/jm401963n |
| None |
NON-PROTEIN TARGET |
Fu |
0.48 |
None |
10.1124/dmd.111.043984 |
| None |
NON-PROTEIN TARGET |
Fu |
0.92 |
None |
10.1124/dmd.112.045476 |
| None |
NON-PROTEIN TARGET |
Fu |
nan |
None |
10.1124/dmd.112.045476 |
| None |
NON-PROTEIN TARGET |
GI |
nan |
None |
10.1016/j.ejmech.2016.08.027 |
| None |
NON-PROTEIN TARGET |
Potency |
1.9 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
840.7 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
943.3 |
nM |
None |
| None |
No relevant target |
LogD |
2.35 |
None |
10.1021/acs.jmedchem.2c01079 |
| None |
No relevant target |
LogD |
2.4 |
None |
10.1021/acs.jmedchem.0c01033 |
| None |
No relevant target |
LogD7.4 |
2.21 |
None |
10.6019/CHEMBL3301361 |
| None |
No relevant target |
-log(solubility) |
4.39 |
None |
10.1016/j.bmcl.2015.02.013 |
| None |
No relevant target |
-log(solubility) |
4.41 |
None |
10.1016/j.bmcl.2015.02.013 |
| None |
No relevant target |
-log(solubility) |
4.53 |
None |
10.1016/j.bmcl.2015.02.013 |
| None |
No relevant target |
-log(solubility) |
5.11 |
None |
10.1016/j.bmcl.2015.02.013 |
| None |
No relevant target |
-log(solubility) |
5.19 |
None |
10.1016/j.bmcl.2015.02.013 |
| None |
No relevant target |
-log(solubility) |
5.41 |
None |
10.1016/j.bmcl.2015.02.013 |
| None |
No relevant target |
-log(solubility) |
5.64 |
None |
10.1016/j.bmcl.2015.02.013 |
| None |
No relevant target |
-log(solubility) |
5.71 |
None |
10.1016/j.bmcl.2015.02.013 |
| None |
No relevant target |
Papp |
30.0 |
ucm/s |
10.1124/dmd.112.045476 |
| None |
No relevant target |
pKa |
3.2 |
None |
10.1021/acs.jmedchem.0c01033 |
| None |
No relevant target |
pKa |
3.6 |
None |
10.1021/acs.jmedchem.2c01079 |
| None |
No relevant target |
pKa |
4.2 |
None |
10.1021/acs.jmedchem.0c01033 |
| None |
Nucleic Acid |
Ratio |
0.67 |
None |
10.1124/dmd.112.045476 |
| None |
Nucleic Acid |
Ratio |
1.24 |
None |
10.1124/dmd.111.043984 |
| None |
Nucleic Acid |
Rblood_plasma |
0.54 |
None |
10.1124/dmd.110.037457 |
| None |
Nucleic Acid |
Rblood_plasma |
1.16 |
None |
10.1124/dmd.110.037457 |
| None |
Nucleic Acid |
Rblood_plasma |
1.18 |
None |
10.1124/dmd.110.037457 |
| None |
Nucleic Acid |
Rblood_plasma |
1.24 |
None |
10.1124/dmd.110.037457 |
| None |
Nucleic Acid |
Rblood_plasma |
1.25 |
None |
10.1124/dmd.110.037457 |
| None |
Unchecked |
Ac50 |
2.512 |
uM |
None |
| None |
Unchecked |
Ac50 |
2.818 |
uM |
None |
| None |
Unchecked |
Ac50 |
3.162 |
uM |
None |
| None |
Unchecked |
AC50 |
2511.9 |
nM |
None |
| None |
Unchecked |
AC50 |
2818.4 |
nM |
None |
| None |
Unchecked |
AC50 |
3162.3 |
nM |
None |
| None |
Unchecked |
Activity |
48.0 |
% |
10.1021/acs.jmedchem.0c00262 |
| None |
Unchecked |
Activity |
63.0 |
% |
10.1016/j.ejmech.2020.112258 |
| None |
Unchecked |
Activity |
70.0 |
% |
10.1016/j.bmc.2010.06.102 |
| None |
Unchecked |
Activity |
nan |
None |
10.1016/j.ejmech.2016.03.021 |
| None |
Unchecked |
Activity |
nan |
None |
10.1016/j.ejmech.2020.112258 |
| None |
Unchecked |
EC50 |
4700.0 |
nM |
10.1021/acsmedchemlett.2c00511 |
| None |
Unchecked |
IC50 |
3.8 |
nM |
10.1016/j.ejmech.2016.03.021 |
| None |
Unchecked |
IC50 |
13700.0 |
nM |
10.1021/acs.jmedchem.2c01079 |
| None |
Unchecked |
IC50 |
72500.0 |
nM |
None |
| None |
Unchecked |
IC50 |
80000.0 |
nM |
None |
| None |
Unchecked |
Inhibition |
54.0 |
% |
10.1016/j.ejmech.2020.112258 |
| None |
Unchecked |
Inhibition |
56.0 |
% |
10.1016/j.ejmech.2020.112258 |
| None |
Unchecked |
Ki |
2.75 |
nM |
10.1016/j.ejmech.2016.03.021 |
| None |
Unchecked |
Ki |
3.7 |
nM |
10.1016/j.bmc.2010.10.043 |
| None |
Unchecked |
Potency |
4.2 |
nM |
None |
| None |
Unchecked |
Potency |
1258.9 |
nM |
None |
| None |
Unchecked |
Potency |
16626.1 |
nM |
None |
| None |
Unchecked |
Potency |
20931.0 |
nM |
None |
| None |
Unchecked |
Potency |
22387.2 |
nM |
None |
| None |
Unchecked |
Potency |
26350.6 |
nM |
None |
| None |
Unchecked |
Potency |
31622.8 |
nM |
None |
| None |
Unchecked |
Potency |
36125.4 |
nM |
None |
| None |
Unchecked |
Potency |
37221.2 |
nM |
None |
| None |
Unchecked |
Potency |
46858.7 |
nM |
None |
| None |
Unchecked |
Ratio |
0.002 |
None |
10.1093/toxsci/kft176 |
| None |
Unchecked |
Ratio |
0.004 |
None |
10.1093/toxsci/kft176 |
| None |
Unchecked |
Ratio |
0.009 |
None |
10.1093/toxsci/kft176 |